NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 139 filers reported holding NATERA INC in Q2 2019. The put-call ratio across all filers is 1.60 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,613,000 | +30.8% | 167,242 | -2.3% | 1.42% | +48.3% |
| Q1 2019 | $3,528,000 | -31.3% | 171,117 | -53.5% | 0.96% | -35.1% |
| Q4 2018 | $5,137,000 | -33.1% | 367,967 | +14.7% | 1.48% | +13.0% |
| Q3 2018 | $7,681,000 | -6.0% | 320,863 | -26.1% | 1.31% | +0.4% |
| Q2 2018 | $8,168,000 | +60.4% | 434,002 | -21.0% | 1.30% | +56.2% |
| Q1 2018 | $5,091,000 | +3.4% | 549,177 | +0.3% | 0.84% | +19.1% |
| Q4 2017 | $4,923,000 | -30.1% | 547,577 | +0.2% | 0.70% | -31.7% |
| Q3 2017 | $7,041,000 | +28.3% | 546,252 | +8.1% | 1.03% | +26.5% |
| Q2 2017 | $5,490,000 | – | 505,500 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |